Huntsman Cancer Institute, Salt Lake City, Utah.
Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):126-135. doi: 10.1158/1055-9965.EPI-23-0679.
Cardiotoxicity among breast cancer survivors is associated with chemotherapy and radiation therapy. The risk of cardiovascular disease (CVD) among Asian, Native Hawaiian and Pacific Islander (ANHPI) breast cancer survivors in the United States is unknown.
We used the SEER-Medicare linked database to estimate the risk of CVD among older breast cancer survivors. International Classification of Disease diagnosis codes were used to identify incident CVD outcomes. Cox proportional hazards models were used to estimate HRs and 95% confidence intervals (CI) comparing ANHPI with Non-Hispanic White (NHW) patients with breast cancer for CVD, and among ANHPI race and ethnicity groups.
A total of 7,122 ANHPI breast cancer survivors and 21,365 NHW breast cancer survivors were identified. The risks of incident heart failure and ischemic heart disease were lower among ANHPI compared with NHW breast cancer survivors (HRheart failure, 0.72; 95% CI, 0.61-0.84; HRheart disease, 0.74; 95% CI, 0.63-0.88). Compared with Japanese patients with breast cancer, Filipino, Asian Indian and Pakistani, and Native Hawaiian breast cancer survivors had higher risks of heart failure. ischemic heart disease and death. Among ANHPI breast cancer survivors, risk factors for heart failure included older age, higher comorbidity score, distant cancer stage and chemotherapy.
Our results support heterogeneity in CVD outcomes among breast cancer survivors among ANHPI race and ethnicity groups. Further research is needed to elucidate the disparities experienced among ANHPI breast cancer survivors.
Filipino, Asian Indian and Pakistani, and Native Hawaiian patients with breast cancer had higher risks of heart failure, ischemic heart disease and death among ANHPI patients with breast cancer.
乳腺癌幸存者的心脏毒性与化疗和放疗有关。在美国,亚洲、夏威夷原住民和太平洋岛民(ANHPI)乳腺癌幸存者患心血管疾病(CVD)的风险尚不清楚。
我们使用 SEER-Medicare 关联数据库来估计老年乳腺癌幸存者 CVD 的风险。使用国际疾病分类诊断代码来识别 CVD 结局。使用 Cox 比例风险模型来估计 HRs 和 95%置信区间(CI),比较 ANHPI 与非西班牙裔白人(NHW)乳腺癌患者的 CVD,并比较 ANHPI 种族和族裔群体之间的 CVD。
共确定了 7122 名 ANHPI 乳腺癌幸存者和 21365 名 NHW 乳腺癌幸存者。与 NHW 乳腺癌幸存者相比,ANHPI 乳腺癌幸存者发生心力衰竭和缺血性心脏病的风险较低(心力衰竭 HR,0.72;95%CI,0.61-0.84;心脏病 HR,0.74;95%CI,0.63-0.88)。与日本乳腺癌患者相比,菲律宾、亚裔印度人和巴基斯坦人以及夏威夷原住民乳腺癌幸存者心力衰竭、缺血性心脏病和死亡的风险更高。在 ANHPI 乳腺癌幸存者中,心力衰竭的危险因素包括年龄较大、合并症评分较高、远处癌症分期和化疗。
我们的研究结果支持 ANHPI 种族和族裔群体中乳腺癌幸存者 CVD 结局的异质性。需要进一步研究来阐明 ANHPI 乳腺癌幸存者所经历的差异。
与 ANHPI 乳腺癌幸存者中的其他群体相比,菲律宾、亚裔印度人和巴基斯坦人以及夏威夷原住民的乳腺癌患者心力衰竭、缺血性心脏病和死亡的风险更高。